Abbott Laboratories
Registered Principal Details
Business Or Interest:
Discover, manufacture and sell health care products.
Lobbying Interests:
Medicaid as it pertains to prescription drugs. Regulations related to prescription drug industry.
CEO Name:
Miles White
Regional Director
Discover, manufacture and sell health care products.
Lobbying Interests:
Medicaid as it pertains to prescription drugs. Regulations related to prescription drug industry.
CEO Name:
Miles White
Regional Director
Contact
CS
Charles Seeds
1406 Plumwood Drive
Libertyville, IL 60048
(847) 816-3935
(847) 281-9408
charles.seeds@abbott.com
www.abbott.com
1406 Plumwood Drive
Libertyville, IL 60048
(847) 816-3935
(847) 281-9408
charles.seeds@abbott.com
www.abbott.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Peter Kammer | Exclusive Duties N/A | Authorized On 3/7/2011 | Withdrawn On N/A |
| Heather Berlinski | Exclusive Duties N/A | Authorized On 3/7/2011 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 151
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
6/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
Other
Notification Date6/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 101
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
6/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
Other
Notification Date6/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 373
Relating to: changes to product liability law and the law governing remedies against manufacturers, distributors, sellers, and promoters of a product.
Bill Text and History
1/12/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: changes to product liability law and the law governing remedies against manufacturers, distributors, sellers, and promoters of a product.
Bill Text and History
None
Notification Date1/12/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
September 2011 Special Session Assembly Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
10/21/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
For
Notification Date10/21/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs
Health Services: Medical Assistance and Related Programs
Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Medicaid reimbursement
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Medicaid reimbursement
Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
drug substitution
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
drug substitution
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Health care reform including health insurance exchanges
Health care reform including health insurance exchanges
Action Intended To Affect
Legislative matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Health care reform including health insurance exchanges
Health care reform including health insurance exchanges
Action Intended To Affect
Legislative Matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Combined reporting of corporate income.
Combined reporting of corporate income.
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicaid funding.
Medicaid funding.
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Relating to prohibiting the manufacture and sale of bottles and cups containing bisphenal-A.
Relating to prohibiting the manufacture and sale of bottles and cups containing bisphenal-A.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Development, drafting or introduction of a proposal relating to
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2011 January - June $3,300.00 |
2011 July - December $7,650.00 |
2012 January - June $5,062.50 |
2012 July - December $2,800.00 |
Total $18,812.50 |
| Total Hours Communicating | 2011 January - June 2.50 |
2011 July - December 9.25 |
2012 January - June 4.50 |
2012 July - December 0.00 |
Total 16.25 |
| Total Hours Other | 2011 January - June 14.00 |
2011 July - December 41.75 |
2012 January - June 29.25 |
2012 July - December 14.00 |
Total 99.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 10% |
2011 July - December 20% |
2012 January - June |
2012 July - December |
Total 10% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 10% |
2011 July - December 20% |
2012 January - June |
2012 July - December |
Total 10% |
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 50% |
2012 January - June |
2012 July - December |
Total 23% |
Budget Bill Subjects
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 70% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 10% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June 90% |
2012 July - December |
Total 26% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December 100% |
Total 12% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication